Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer's disease

Journal of Neural Transmission

Volumn 113, Issue 11, 2006, Pages 1763-1769

  Kessler, H ^a   Pajonk, F G ^a   Meisser, P ^a   Schneider Axmann, T ^a   Hoffmann, K H ^a   Supprian, T ^a   Herrmann, W ^a   Obeid, R ^a   Multhaup, G ^b   Falkai, P ^a   Bayer, T A ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Alzheimer's disease; Copper; CSF

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BIOLOGICAL MARKER; CERULOPLASMIN; COPPER; NEUROTRANSMITTER; TAU PROTEIN; ZINC;

ADULT; ALZHEIMER DISEASE; ARTICLE; BLOOD SAMPLING; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LABORATORY DIAGNOSIS; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BIOLOGICAL MARKERS; CERULOPLASMIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COPPER; FEMALE; HUMANS; MALE; NEUROTRANSMITTER AGENTS; SPECTROPHOTOMETRY, ATOMIC; TAU PROTEINS; ZINC;

EID: 33750463720     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-006-0485-7     Document Type: Article

References (38)

1. N Andreasen M Sjogren K Blennow 2003 CSF markers for Alzheimer's disease: total tau, phospho-tau and Abeta42 World J Biol Psychiatry 4 147 155
2. B Angeletti KJ Waldron KB Freeman H Bawagan I Hussain CC Miller KF Lau ME Tennant C Dennison NJ Robinson C Dingwall 2005 BACE1 cytoplasmic domain interacts with the copper chaperone for superoxide dismutase-1 and binds copper J Biol Chem 280 17930 17937
3. CS Atwood RC Scarpa X Huang RD Moir WD Jones DP Fairlie RE Tanzi AI Bush 2000 Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42 J Neurochem 75 1219 1233
4. KJ Barnham WJ [tmp] McKinstry G Multhaup D Galatis CJ Morton CC Curtain NA Williamson AR White MG Hinds RS Norton K Beyreuther CL Masters MW Parker R Cappai 2003 Structure of the Alzheimer's disease amyloid precursor protein copper binding domain. A regulator of neuronal copper homeostasis J Biol Chem 278 17401 17407
5. TB Bartnikas JD Gitlin 2003 Mechanisms of biosynthesis of mammalian copper/zinc superoxide dismutase J Biol Chem 278 33602 33608
6. TA Bayer R Cappai CL Masters K Beyreuther G Multhaup 1999 It all sticks together-the APP-related family of proteins and Alzheimer's disease Mol Psychiatry 4 524 528
7. TA Bayer S Schäfer A Simons A Kemmling T Kamer R Tepest A Eckert K Schüssel O Eikenberg C Sturchler-Pierrat D Abramowski M Staufenbiel G Multhaup 2003 Dietary Cu stabilizes brain SOD-1 activity and reduces amyoid Aβ production in APP23 transgenic mice PNAS 100 14187 14192
8. MF Beal JH Growdon 1986 CSF neurotransmitter markers in Alzheimer's disease Prog Neuropsychopharmacol Biol Psychiatry 10 259 270
9. T Borchardt J Camakaris R Cappai CL Masters K Beyreuther G Multhaup 1999 Copper inhibits beta-amyloid production and stimulates the non-amyloidogenic pathway of amyloid-precursor-protein secretion Biochem J 344 461 467
10. AI Bush 2003 The metallobiology of Alzheimer's disease Trends Neurosci 26 207 214
11. RA Cherny CS Atwood ME Xilinas DN Gray WD Jones CA [tmp] McLean KJ Barnham I Volitakis FW Fraser Y Kim X Huang LE Goldstein RD Moir JT Lim K Beyreuther H Zheng RE Tanzi CL Masters AI Bush 2001 Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease Transgenic Mice Neuron 30 665 676
12. JR Connor P Tucker M Johnson B Snyder 1993 Ceruloplasmin levels in the human superior temporal gyrus in aging and Alzheimer's disease Neurosci Lett 159 88 90
13. MA Deibel WD Ehmann WR Markesbery 1996 Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress J Neurol Sci 143 137 142
14. C Gonzalez T Martin J Cacho MT Brenas T Arroyo B Garcia-Berrocal JA Navajo JM Gonzalez-Buitrago 1999 Serum zinc, copper, insulin and lipids in Alzheimer's disease epsilon 4 apolipoprotein E allele carriers Eur J Clin Invest 29 637 642
15. CG Gottfries SO Frederiksen M Heilig 1995 Neuropeptides and Alzheimer's disease Eur Neuropsychopharmacol 5 491 500
16. H Hampel SJ Teipel T Fuchsberger N Andreasen J Wiltfang M Otto Y Shen R Dodel Y Du M Farlow HJ Moller K Blennow K Buerger 2004 Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment Mol Psychiatry 9 705 710
17. L Hesse D Beher CL Masters G Multhaup 1994 The beta A4 amyloid precursor protein binding to copper Febs Lett 349 109 116
18. F Hulstaert K Blennow A Ivanoiu HC Schoonderwaldt M Riemenschneider PP De Deyn C Bancher P Cras J Wiltfang PD Mehta K Iqbal H Pottel E Vanmechelen H Vanderstichele 1999 Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF Neurology 52 1555 1562
19. C Jeandel MB Nicolas F Dubois F Nabet-Belleville F Penin G Cuny 1989 Lipid peroxidation and free radical scavengers in Alzheimer's disease Gerontology 35 275 282
20. P Lewczuk H Esselmann M Otto JM Maler AW Henkel MK Henkel O Eikenberg C Antz WR Krause U Reulbach J Kornhuber J Wiltfang 2004 Neurochemical diagnosis of Alzheimer's dementia by CSF Abeta42, Abeta42/Abeta40 ratio and total tau Neurobiol Aging 25 273 281
21. DA Loeffler PA LeWitt PL Juneau AA Sima HU Nguyen AJ DeMaggio CM Brickman GJ Brewer RD Dick MD Troyer L Kanaley 1996 Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders Brain Res 738 265 274
22. MA Lovell JD Robertson WJ Teesdale JL Campbell WR Markesbery 1998 Copper, iron and zinc in Alzheimer's disease senile plaques J Neurol Sci 158 47 52
23. A Maddalena A Papassotiropoulos B Muller-Tillmanns HH Jung T Hegi RM Nitsch C Hock 2003 Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to beta-amyloid peptide 42 Arch Neurol 60 1202 1206
24. CJ Maynard R Cappai I Volitakis RA Cherny AR White K Beyreuther CL Masters AI Bush QX Li 2002 Overexpression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron J Biol Chem 277 44670 44676
25. G [tmp] McKhann D Drachman M Folstein R Katzman D Price EM Stadlan 1984 Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 939 944
26. DM [tmp] McLoughlin CL Standen KF Lau S Ackerley TP Bartnikas JD Gitlin CC Miller 2001 The neuronal adaptor protein X11alpha interacts with the copper chaperone for SOD1 and regulates SOD1 activity J Biol Chem 276 9303 9307
27. MA Mena EG Aguado JG de Yebenes 1984 Monoamine metabolites in human cerebrospinal fluid. HPLC/ED method Acta Neurol Scand 69 218 225
28. G Multhaup A Schlicksupp L Hesse D Beher T Ruppert CL Masters K Beyreuther 1996 The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I) Science 271 1406 1409
29. F Pajonk H Kessler T Supprian P Hamzei D Bach J Schweickhardt W Herrmann R Obeid A Simons P Falkai G Multhaup T Bayer 2005 Cognitive decline correlates with low plasma concentrations of copper in patients with mild to moderate Alzheimer's disease J Alzheimers Dis 8 23 27
30. AL Phinney B Drisaldi S Lugowski S Schmidt H Bonek Y Liang P Home L Yang J Sekoulidis J Coomaraswarmy D Cox PM Mathews RA Nixon GA Carlson P St George-Hyslop D Westaway 2003 In vivo reduction of amyloid Aβ by a mutant copper transporter PNAS 100 14193 14198
31. V Rizzo A Anesi L Montalbetti G Bellantoni R Trotti GV Melzi d'Eril 1996 Reference values of neuroactive amino acids in the cerebrospinal fluid by high-performance liquid chromatography with electrochemical and fluorescence detection J Chromatogr A 729 181 188
32. NS Schoonenboom YA Pijnenburg C Mulder SM Rosso EJ Van Elk GJ Van Kamp JC Van Swieten P Scheltens 2004 Amyloid beta(1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease Neurology 62 1580 1584
33. J Snaedal J Kristinsson S Gunnarsdottir E Olafsdottir M Baldvinsson T Johannesson 1998 Copper, ceruloplasmin and superoxide dismutase in patients with Alzheimer's disease. A case-control study Dement Geriatr Cogn Disord 9 239 242
34. R Squitti D Lupoi P Pasqualetti G Dal Forno F Vernieri P Chiovenda L Rossi M Cortesi E Cassetta PM Rossini 2002 Elevation of serum copper levels in Alzheimer's disease Neurology 59 1153 1161
35. G Torsdottir J Kristinsson S Hreidarsson J Snaedal T Johannesson 2001 Copper, ceruloplasmin and superoxide dismutase (SOD1) in patients with Down's syndrome Pharmacol Toxicol 89 320 325
36. C Treiber A Simons M Strauss M Hafner R Cappai TA Bayer G Multhaup 2004 Clioquinol Mediates Copper Uptake and Counteracts Copper Efflux Activities of the Amyloid Precursor Protein of Alzheimer's Disease J Biol Chem 279 51958 51964
37. JR Turnlund RA Jacob CL Keen JJ Strain DS Kelley JM Domek WR Keyes JL Ensunsa J Lykkesfeldt J Coulter 2004 Long-term high copper intake: effects on indexes of copper status, antioxidant status, and immune function in young men Am J Clin Nutr 79 1037 1044
38. AR White R Reyes JF Mercer J Camakaris H Zheng AI Bush G Multhaup K Beyreuther CL Masters R Cappai 1999 Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice Brain Res 842 439 444